TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an update.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for December 9, 2025, to discuss significant changes including the abolishment of the Supervisory Board and amendments to the Articles of Association. These proposals, if approved, could streamline the company’s governance structure and potentially impact its operational efficiency and shareholder engagement.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 3,317,118
Technical Sentiment Signal: Buy
Current Market Cap: HK$67.18B
See more insights into 2607 stock on TipRanks’ Stock Analysis page.